Plain-English translation of NCT05241028 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called as a follow-up treatment after you've had surgery to remove early-stage lung cancer. You would take this medication by mouth every day for up to three years. The goal is to see if this treatment can help prevent your cancer from coming back.
After surgery removes lung cancer, there's still a risk it could return. Doctors want to find out if giving this medication after surgery—rather than waiting to see if cancer comes back—can improve your chances of staying cancer-free long-term.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would take a daily oral dose of the medication and visit the study center regularly for check-ups, blood tests, and imaging scans to monitor for side effects and cancer recurrence. You would continue this treatment for three years unless your cancer returns or you experience intolerable side effects. The study involves about 80 participants across multiple hospitals.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China